Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      T Rajasekar appointed as HLL Director

      T Rajasekar appointed as HLL Director

      supriya kashyap kashyap4 April 2017 11:30 AM IST
      Thiruvananthapuram : T Rajasekar has been appointed as the new Director (Marketing) of Central PSU HLL Lifecare Limited by the Union Ministry of...
      The cost of cancer: new drugs show success at a steep price

      The cost of cancer: new drugs show success at a steep price

      supriya kashyap kashyap4 April 2017 11:29 AM IST
      Newer cancer drugs that enlist the body's immune system are improving the odds of survival, but competition between them is not reining in prices that...
      Sanofi fined $19.9 million for overcharging

      Sanofi fined $19.9 million for overcharging

      supriya kashyap kashyap4 April 2017 11:26 AM IST
      The vaccines unit of French pharmaceutical company Sanofi SA will pay a $19.9 million fine for overcharging the U.S. Department of Veterans Affairs...
      Apax to buy Israeli aesthetic device firm Syneron for $397 mln

      Apax to buy Israeli aesthetic device firm Syneron for $397 mln

      supriya kashyap kashyap4 April 2017 11:25 AM IST
      TEL AVIV : British private equity firm Apax Partners has agreed to buy Israel's Syneron Medical Ltd, a non-surgical aesthetic device company, for...
      Cadila gets stakeholders nod for scheme of arrangement with Zydus

      Cadila gets stakeholders nod for scheme of arrangement with Zydus

      supriya kashyap kashyap3 April 2017 11:36 AM IST
      New Delhi : Drug firm Cadila Healthcare has received overwhelming approval from stakeholders for scheme of arrangement between the company and Zydus...
      MED-EL announces expansion in India to restore hearing abilities among deaf

      MED-EL announces expansion in India to restore hearing abilities among deaf

      supriya kashyap kashyap3 April 2017 11:33 AM IST
      New Delhi : MED-EL India, the Indian subsidiary of the global leading provider of hearing implant systems MED-EL, known for developing innovative...
      Drugs being developed under the AYUSH system of medicine, Check out details

      Drugs being developed under the AYUSH system of medicine, Check out details

      supriya kashyap kashyap3 April 2017 11:32 AM IST
      Central Council for Research in Ayurvedic Sciences (CCRAS) has developed anti-diabetic drug AYUSH-82 and AYUSH-SG for Rheumetoid Arthritis. Central...
      FDA approves Qudexy XR for migraine prophylaxis in adults, adolescents

      FDA approves Qudexy XR for migraine prophylaxis in adults, adolescents

      supriya kashyap kashyap3 April 2017 11:31 AM IST
      The FDA has approved two supplemental new drug applications for Qudexy XR extended-release capsules, a once-daily prophylactic medication for migraine...
      FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr

      FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr

      supriya kashyap kashyap2 April 2017 11:49 AM IST
      The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen...
      FDA approves new drug to treat multiple sclerosis

      FDA approves new drug to treat multiple sclerosis

      supriya kashyap kashyap2 April 2017 11:46 AM IST
      The U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and...
      Hilleman Laboratories Signs MoU With NICED, ICMR to Develop Shigella Vaccine

      Hilleman Laboratories Signs MoU With NICED, ICMR to Develop Shigella Vaccine

      supriya kashyap kashyap2 April 2017 11:31 AM IST
      New Delhi : Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, signed a Memorandum of Understanding (MoU) with...
      Funding in Healthcare: Key features from NATHEALTH-PwC Report

      Funding in Healthcare: Key features from NATHEALTH-PwC Report

      supriya kashyap kashyap2 April 2017 11:28 AM IST
      New Delhi : To bridge the huge infrastructure gap, India will need much more participation from the private sector and for these conventional modes of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok